Targeting MAPK Signaling in Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is a major cause of irreversible blindness affecting elderly people in the world. AMD is a complex multifactorial disease associated with demographic, genetics, and environmental risk factors. It is well established that oxidative stress, inflammation, and apop...
Main Author: | Svetlana V. Kyosseva |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-01-01
|
Series: | Ophthalmology and Eye Diseases |
Online Access: | https://doi.org/10.4137/OED.S32200 |
Similar Items
-
Targeting MAPK Signaling in Age-Related Macular Degeneration
by: Svetlana V. Kyosseva
Published: (2016-06-01) -
Targeting Tissue Lipids in Age-related Macular Degeneration
by: Rajendra S. Apte
Published: (2016-03-01) -
Targeted therapy in age-related macular degeneration (AMD)
by: Klaudia Daria Szumna, et al.
Published: (2020-03-01) -
APOE2 promotes the development and progression of subretinal neovascularization in age-related macular degeneration via MAPKs signaling pathway
by: Yiwen Sun, et al.
Published: (2020-10-01) -
Age-related macular degeneration
by: Wanjiku Mathenge
Published: (2014-12-01)